MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations

NCT01827384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

NIH

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm

Interventions

DRUG: Adavosertib
DRUG: Carboplatin
DRUG: Everolimus
DRUG: Temozolomide
DRUG: Trametinib
DRUG: Veliparib

Sponsor

National Cancer Institute (NCI)